Regeneron Pharmaceuticals, Inc. (LON:0R2M)
744.27
-2.54 (-0.34%)
At close: Jan 30, 2026
Regeneron Pharmaceuticals Employees
Regeneron Pharmaceuticals had 15,222 employees as of September 30, 2025. The number of employees increased by 1,057 or 7.46% compared to the same quarter last year.
Employees
15,222
Change
1,057
Growth
7.46%
Revenue / Employee
700.09K GBP
Profits / Employee
219.89K GBP
Market Cap
55.45B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 15,222 | 1,057 | 7.46% |
| Jun 30, 2025 | 15,182 | 1,256 | 9.02% |
| Mar 31, 2025 | 15,158 | 1,481 | 10.83% |
| Dec 31, 2024 | 15,106 | 1,656 | 12.31% |
| Sep 30, 2024 | 14,165 | 1,702 | 13.66% |
| Jun 30, 2024 | 13,926 | 1,670 | 13.63% |
| Mar 31, 2024 | 13,677 | 1,578 | 13.04% |
| Dec 31, 2023 | 13,450 | 1,599 | 13.49% |
| Sep 30, 2023 | 12,463 | 1,548 | 14.18% |
| Jun 30, 2023 | 12,256 | 1,541 | 14.38% |
| Mar 31, 2023 | 12,099 | 1,607 | 15.32% |
| Dec 31, 2022 | 11,851 | 1,483 | 14.30% |
| Sep 30, 2022 | 10,915 | 1,149 | 11.77% |
| Jun 30, 2022 | 10,715 | 1,080 | 11.21% |
| Mar 31, 2022 | 10,492 | 1,045 | 11.06% |
| Dec 31, 2021 | 10,368 | 1,245 | 13.65% |
| Sep 30, 2021 | 9,766 | 1,452 | 17.46% |
| Jun 30, 2021 | 9,635 | 1,493 | 18.34% |
| Mar 31, 2021 | 9,447 | 1,417 | 17.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,000 |
| Convatec Group | 10,000 |
| Hikma Pharmaceuticals | 9,500 |
| CVS Group | 8,850 |
| Genus | 3,190 |
Regeneron Pharmaceuticals News
- 5 days ago - HCR Wealth Advisors Buys 286 Shares of Regeneron Pharmaceuticals Inc (REGN) - GuruFocus
- 5 days ago - Lipe & Dalton Buys 309 Shares of Regeneron Pharmaceuticals Inc (REGN) - GuruFocus
- 6 days ago - Opal Wealth Advisors, LLC Buys 343 Shares of Regeneron Pharmaceuticals Inc (REGN) - GuruFocus
- 8 days ago - Goldman Sachs Strategic Factor Allocation Fund Buys 1,727 Shares of Regeneron Pharmaceuticals ... - GuruFocus
- 8 days ago - Bridgewater Advisors Inc. Buys 322 Shares of Regeneron Pharmaceuticals Inc (REGN) - GuruFocus
- 8 days ago - Voya Large-Cap Growth Fund Buys 5,481 Shares of Regeneron Pharmaceuticals Inc (REGN) - GuruFocus
- 8 days ago - Voya Large Cap Value Fund Buys 7,862 Shares of Regeneron Pharmaceuticals Inc (REGN) - GuruFocus
- 9 days ago - Regeneron: Q4 Earnings Preview - Why I'm Expecting A Beat And Strong 2026 - Seeking Alpha